Non idiopathic pulmonary fibrosis trang 1 tải miễn phí từ TAILIEUCHUNG

"Non idiopathic pulmonary fibrosis" trang 1 - tải miễn phí từ Tailieuchung

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: Impact on survival and acute exacerbation

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: Impact on survival and acute exacerbation

8 22 1

Survival in Idiopathic pulmonary fibrosis acute exacerbations: The non-steroid approach

Survival in Idiopathic pulmonary fibrosis acute exacerbations: The non-steroid approach

9 42 1

In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: A comparison of academic and non-academic programs

In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: A comparison of academic and non-academic programs

11 40 1

Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: A case report

Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: A case report

5 27 1

Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonia: Associations with acute exacerbation and overall survival

Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonia: Associations with acute exacerbation and overall survival

9 22 1

Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, doubleblind, placebo-controlled, parallel group, multi-center, phase II trial

Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, doubleblind, placebo-controlled, parallel group, multi-center, phase II trial

9 13 1

Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights

Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights

13 19 1

Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease

Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease

8 28 1

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases

9 26 1

Management of chronic respiratory failure in interstitial lung diseases: Overview and clinical insights

Management of chronic respiratory failure in interstitial lung diseases: Overview and clinical insights

14 63 0

Role and new insights of pirfenidone in fibrotic diseases

Role and new insights of pirfenidone in fibrotic diseases

8 80 0

The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts

The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts

9 42 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.